INVESTOR RELATIONS OVERVIEW
Webcast ImageWebcast
Icagen Inc at JPMorgan Healthcare Conference (Replay)
01/14/10 at 11:30 a.m. PT
Stock Quote
ICGN (Common Stock)
PriceChange% ChangeVolume
$0.79 + 0.022.60%85,108
Previous CloseToday's OpenIntraday HighIntraday Low
$0.77$0.80$0.80$0.72
Financial Status Indicator: D
02/08/10 3:57 p.m. ET
Minimum 20 minute delay   Refresh quote
Corporate Profile
Icagen is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads.

Ion channels are protein structures found in virtually every cell of the human body. Ion channels span the cell membrane and regulate the flow of ions, which are charged particles such as sodium, potassium, calcium and chloride, into and out of cells. There are currently 35 drugs that modulate ion channels and are marketed by third par... + more
Annual Reports
Download Documentation 2008 Annual Report
Download Documentation 2009 Proxy
Get help downloading or viewing the above file types
Recent NewsRSS Feeds   |   + more
DateTitle 
01/04/10Icagen to Present at the JP Morgan Healthcare ConferencePrinter Friendly Version
12/01/09Icagen to Present at the 63rd Annual Meeting of the American Epilepsy SocietyPrinter Friendly Version
11/13/09Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance With Continued Listing RequirementsPrinter Friendly Version
11/05/09Icagen Reports Third Quarter 2009 Financial Results and Operational HighlightsPrinter Friendly Version
Upcoming Events+ more
There are currently no events scheduled.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Icagen, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


IR Overview
Press Releases
Stock Information
Analyst Coverage
Earnings Estimates
SEC Filings
Events Calendar
Webcasts & Presentations
Corporate Governance
Information Request
E-mail Alerts




 Contact Us     Directions      Site MapCopyright © 2007 Icagen, Inc.   All rights reserved